Inhibition of drug metabolizing cytochrome P450s by the aromatase inhibitor drug letrozole and its major oxidative metabolite 4,4′-methanol-bisbenzonitrile in vitro

Author： Jeong Seongwook   Woo Margaret   Flockhart David   Desta Zeruesenay  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.64, Iss.5, 2009-10, pp. : 867-875

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Inhibitors of Steroidal Cytochrome P450 Enzymes as Targets for Drug Development

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 2, Iss. 1, 2007-01 ,pp. : 31-58

Bentham Science Publishers

Access to resources Recommend Favorite

A Potential Role for the Estrogen-metabolizing Cytochrome P450 Enzymes in Human Breast Carcinogenesis

By Modugno Francesmary  

Breast Cancer Research and Treatment, Vol. 82, Iss. 3, 2003-01 ,pp. : 191-197

Springer Publishing Company

Access to resources Recommend Favorite

Aromatase: The Enzyme and Its Inhibition

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 6, 2009-07 ,pp. : 627-641

Bentham Science Publishers

Access to resources Recommend Favorite

Cytochrome P450 3A-mediated metabolism of the topoisomerase I inhibitor 9-aminocamptothecin: Ιmpact on cancer therapy

By              

International Journal of Oncology, Vol. 45, Iss. 2, 2014-01 ,pp. : 877-886

Spandidos Publications

Access to resources Recommend Favorite

Inhibition of the enzyme activity of cytochrome P450 1A1, 1A2 and 3A4 by fucoxanthin, a marine carotenoid

By    

Oncology Letters, Vol. 6, Iss. 3, 2013-01 ,pp. : 860-864

Spandidos Publications

Access to resources Recommend Favorite